The University City-based 1315 Capital is aiming to make investments of up to $20 million in promising life sciences companies.
June 15, 2016 | Technical.ly by Roberto Torres
As of today, there’s $200 million in fresh investment money looking for a new home. But you have to dream big. The funding is meant for companies that “have the potential to generate $100 million a year in revenue.”
So says University City-based 1315 Capital. The growth-equity firm announced Wednesday the closing of a $200 million fund aimed at commercial-stage pharma, medical and healthcare services companies.